Biopharma Daily Stock Updates - 04/16/21

$ZGNX -3.4% New findings of FINTEPLA on patients with Dravet Syndrome. source

$SNDX -2.7% AUGMENT-101 Data Update call on April 20, 2021. source

$TGTX -2.3% Positive Phase 3 trial data reported. source

$IDYA -0.5% Darovasertib monotherapy trial reports overall survival data. source

$APRE +7.6% R&D Day on 4/22/2021 will report analysis of Phase 3 completed trial. source

$AZN -0.2% Receives US clearance to acquire Alexion Pharmaceuticals. source

$DTIL -1.9% Reacquires global rights to allogeneic Car T programs. source